查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1988215

胃束带市场：2026-2032年全球市场预测（依产品类型、年龄层、性别、通路和最终用户划分）

Gastric Bands Market by Product Type, Age Group, Gender, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，胃束带市场价值将达到 6,917 万美元，到 2026 年将成长到 7,867 万美元，到 2032 年将达到 9,818 万美元，复合年增长率为 5.12%。

主要市场统计数据
基准年 2025 6917万美元
预计年份：2026年 7867万美元
预测年份 2032 9818万美元
复合年增长率 (%) 5.12%

现代胃束带疗法和决策受到临床实践变化、设备改进以及对相关人员期望的清晰务实观点。

胃束带疗法的现状正处于临床实用性、器械工程和不断变化的患者期​​望三者交汇之处。胃束带疗法传统上被视为一种微创手术减重方案，近年来，随着植入设计、生理食盐水填充优化和手术全期期方案的不断改进，该通讯协定也持续改进。这些改进影响了临床决策、患者选择标准以及多学科诊疗路径的作用。因此，相关人员现在不仅从临床结果的角度评估胃束带疗法的应用，还从手术效率、病患满意度指标和器械生命週期管理等方面进行考虑。

技术创新、不断发展的护理路径、监管要求和患者行为正在重塑胃束带解决方案的部署和价值交付。

胃束带领域的变革性变化反映了技术进步、医疗服务模式转变以及患者偏好变化的同步发展。器械创新主要集中在可调节系统上，以实现内部限制，其中基于生理盐水的调节方式尤其受到寻求可预测且可逐步调整治疗效果的临床医生的青睐。端口设计、生理食盐水材质和腹腔镜植入技术的创新也减轻了手术负担，并提高了围手术全期安全性。因此，手术团队正在调整工作流程，以适应术后反覆调整和加强病患教育。

2025 年美国关税调整对医疗设备利害关係人的营运和商业影响，包括重组到岸成本、筹资策略和供应链韧性。

2025年美国关税政策的变化为医疗设备供应链带来了重大的物流和商业性挑战，包括胃束带组件和配件的相关问题。进口关税和海关程序的调整影响了接收成本，并促使供应商和医疗采购方在成本分配方面提高透明度。因此，采购团队和经销商越来越重视透明的总拥有成本（TCO）对话，不仅考虑单价，还考虑出货频率、库存管理和退货流量等因素。

这项研究着重于胃束带疗法的细分，将产品设计、分销管道、临床环境和人口统计群体联繫起来，以指导可行的商业化策略。

对市场区隔的精准理解揭示了临床效用、分销动态和患者人口统计特征之间的交集，从而影响产品策略和商业化计划。根据产品类型，医疗器材可分为可调节型和不可调节型。可调节系统，特别是那些配备生理食盐水填充调节机制、允许术后调节和患者个别化管理的系统，是研究的热点。这种差异会影响临床训练需求、追踪频率以及器材的售后服务。

针对美洲、欧洲、中东和非洲以及亚太地区的采购实务、监管复杂性、临床训练系统和病患期望，提供区域性见解。

地理环境塑造了世界各大区域不同的临床实务模式、监管路径、分销物流以及病患期望。在美洲，医疗采购往往集中在大规模医院系统和专科医疗网络中，这些机构强调标准化的采购通讯协定、整合的诊疗路径以及整合的供应商关係。这种环境有利于那些拥有完善的医疗设备培训项目、高效的协调工作流程以及明确的服务承诺的医疗器械，从而最大限度地减少长期追踪中的差异。

竞争与合作的动态，强调产品可靠性、临床医生教育、卓越的售后服务和综合护理伙伴关係，塑造了行业领导地位。

胃束带市场企业的竞争动态受产品工程、临床证据的累积、监管策略以及售后支援服务能力的影响。主要企业将迭代式设备改进与全面的临床医生教育计画和快速的售后服务相结合，使外科团队能够自信地采用适应性强的系统。透过註册登记和长期追踪研究证明设备性能的稳定性，有助于增强临床医生的信心，并促使医疗机构优先采购。

为促进永续采用，提出切实可行的建议，将产品创新、临床医生教育、有韧性的分销网络和证据生成联繫起来。

产业领导企业应优先考虑协作策略，将产品创新、临床应用和分销管道的韧性相结合，以确保临床应用的永续。首先，应投资改进设备设计，简化手术全期操作和术后调整，同时制定标准化的临床医生培训课程，以减少治疗结果的差异，并支持技能的快速传播。标准化通讯协定将有助于顺利融入医院和门诊工作流程，并加强医保报销谈判。

为了得出基于证据的结论，我们采用了严谨的混合方法研究途径，结合了对临床医生的访谈、监管和文献分析、来自分销商的信息以及专家评论。

本研究采用结构化、多方面的方法整合了一手和二手信息，旨在确保研究的严谨性和透明度。一手资讯包括对外科医生、门诊中心主任、采购负责人、分销商高管和临床主任的访谈，以了解他们对器械操作、调整流程和采购考虑的实际观点。除这些定性访谈外，本研究还对同行评审的临床文献、监管申报文件和器械安全资讯揭露进行了系统性回顾，以检验技术声明并识别新出现的安全征兆。

策略整合确定了决定胃束带解决方案永续部署的核心优先事项—临床价值、分销韧性、证据产生和上市后支援。

总之，目前胃束带技术的特点是器械设计日益精密、临床路径不断发展，并且越来越重视上市后证据和供应链的韧性。可调节的生理食盐水填充系统仍然是剂量可调治疗方法和长期患者管理讨论的核心，但其成功不仅取决于器械的功能，还高度依赖于临床医生的培训、便捷的随访以及灵活的配送。监管机构的期望和支付方的审查使得在采购考量中，可证实的安全性和以病人为中心的疗效指标的重要性日益凸显。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：胃束带市场：依产品类型划分

  • 可调节的
  • 不可调节

第九章：胃束带市场：依年龄组别划分

  • 成人版
    • 18-35岁
    • 36-50岁
    • 51岁或以上
  • 儿童

第十章：胃束带市场：性别

  • 女士
  • 男性

第十一章：胃束带市场：依通路划分

  • 直销
  • 销售代理
    • 线上管道
      • 电子商务平台
      • 製造商网站
    • 第三方经销商

第十二章：胃束带市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十三章：胃束带市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：胃束带市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：胃束带市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国胃束带市场

第十七章：中国胃束带市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Allergan plc
  • Apollo Endosurgery, Inc.
  • Cousin Biotech SAS
  • Endo Tools Therapeutics SA
  • EndoGastric Solutions, Inc.
  • Ethicon Endo-Surgery, LLC
  • Hangzhou Kangning Medical Instruments Co., Ltd.
  • Hologic, Inc.
  • JOHNSON & JOHNSON SERVICES, INC.
  • Karl Storz SE & Co. KG
  • Mediflex Surgical Products
  • Medline Industries, LP
  • Medtronic Plc
  • New York Bariatric Group's
  • Obtech Medical AG
  • ReShape Lifesciences Inc.
  • SILIMED INDUSTRIA DE IMPANTES LTDA
  • Spatz FGIA Inc.
  • Surgical Tools, Inc.
  • TedPella Inc.
  • USGI Medical
  • WL Gore & Associates, Inc.
Product Code: MRR-8E373E9E21A8

The Gastric Bands Market was valued at USD 69.17 million in 2025 and is projected to grow to USD 78.67 million in 2026, with a CAGR of 5.12%, reaching USD 98.18 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 69.17 million
Estimated Year [2026] USD 78.67 million
Forecast Year [2032] USD 98.18 million
CAGR (%) 5.12%

A clear and pragmatic orientation to clinical practice shifts, device refinement, and stakeholder expectations framing contemporary gastric band therapy and decision-making

The landscape of gastric band therapy sits at the intersection of clinical pragmatism, device engineering, and evolving patient expectations. Historically positioned as a less invasive surgical option for weight management, gastric band solutions have been continuously refined through advances in implant design, saline fill optimization, and perioperative protocols. These refinements have influenced clinical decision-making, patient selection criteria, and the role of multidisciplinary care pathways. Consequently, stakeholders now evaluate gastric band adoption not only through clinical outcomes but also through procedural efficiency, patient satisfaction metrics, and lifecycle management of the device.

Emerging evidence and practice patterns have prompted clinicians to reassess indications and long-term management strategies, while manufacturers prioritize device reliability, ease of adjustment, and compatibility with minimally invasive techniques. At the same time, payors and institutional purchasers increasingly require robust evidence of safety, consistent follow-up protocols, and demonstrable improvements in patient-reported outcomes. Therefore, an effective introduction to this sector must encompass the converging perspectives of surgeons, interventional clinicians, patients, and procurement specialists, framing gastric bands as one component within a broader continuum of metabolic and bariatric care.

This report's introduction situates gastric band therapy within this complex ecosystem, clarifying clinical pathways, supply considerations, and the strategic trade-offs faced by hospitals, clinics, and ambulatory centers. By synthesizing device-level developments with care delivery realities, readers will gain a pragmatic foundation for the deeper analyses that follow.

How technological innovations, evolving care pathways, regulatory expectations, and patient behavior together are reshaping adoption and value delivery for gastric band solutions

Transformative shifts in the gastric band landscape reflect simultaneous advances in technology, shifts in care delivery models, and changing patient preferences. Device innovations have focused on adjustable systems that permit in situ modulation of restriction, with saline-filled adjustability becoming a focal point for clinicians seeking predictable, titratable outcomes. Innovations in port design, tubing materials, and laparoscopic deployment techniques have also reduced procedural friction and improved perioperative safety profiles. Consequently, surgical teams have adapted workflows to accommodate iterative postoperative adjustments and extended patient education initiatives.

Parallel to device evolution, distribution and purchasing behaviors are changing as health systems pursue supply chain resilience and cost transparency. Digital engagement channels now influence both clinician procurement and patient education, supporting more informed device selection and follow-up adherence. At the same time, regulatory scrutiny and clinical evidence requirements have intensified, prompting manufacturers to invest in postmarket surveillance and real-world evidence generation. These investments are reshaping how clinical value is demonstrated and how reimbursement conversations are framed.

Finally, demographic and lifestyle trends are altering the patient mix that clinicians encounter, which in turn influences device selection and follow-up protocols. Taken together, these transformative shifts require coordinated responses across R&D, clinical affairs, and commercial functions to translate innovation into durable clinical adoption and sustained patient benefit.

Operational and commercial implications of the 2025 U.S. tariff adjustments that reshaped landed costs, procurement strategies, and supply chain resilience for device stakeholders

Tariff policy developments in the United States during 2025 introduced notable logistical and commercial considerations for medical device supply chains, including those relevant to gastric band components and ancillary materials. Adjustments in import duties and customs procedures have influenced landed costs and created a need for clearer cost allocation between suppliers and institutional purchasers. As a result, procurement teams and distributors have increasingly prioritized transparent total-cost-of-ownership conversations, considering not only unit price but also shipment frequency, inventory management, and return logistics.

Operationally, manufacturers and distributors have responded by reassessing sourcing strategies, diversifying supplier bases, and evaluating regional warehousing alternatives to mitigate tariff exposure. Longer-term contractual arrangements with distributors and direct sales agreements have been renegotiated to reflect shifting cost structures, while some suppliers have explored partial localization of assembly or packaging activities to preserve competitiveness. These adaptations have emphasized supply chain agility, with an emphasis on predictable lead times and clear commercial terms.

Clinicians and hospital administrators have also been affected indirectly through procurement timelines and contracting cycles. To navigate the 2025 tariff-related disruptions, stakeholders prioritized transparent supplier communication, contingency inventory planning, and collaborative forecast sharing between device manufacturers and major institutional buyers. In aggregate, the tariff environment acted as a catalyst for supply-chain modernization, pushing stakeholders toward resilient operational models that reduce vulnerability to future policy shifts.

Segmentation-focused insights that tie product design, distribution channels, clinical settings, and demographic cohorts into actionable commercialization strategies for gastric band therapies

A nuanced understanding of segmentation illuminates where clinical utility, distribution dynamics, and patient demographics intersect to influence product strategy and commercialization planning. Based on product type, devices fall into adjustable and non-adjustable categories, with adjustable systems frequently studied for their saline-filled adjustment mechanism that allows postoperative titration and tailored patient management. This differentiation affects clinical training requirements, follow-up cadence, and device service offerings.

Based on distribution channel, sales flow through direct sales relationships and distributor networks, where distributors commonly operate via online channels and third party distributors. Within online channels, e-commerce platforms and manufacturer websites serve distinct roles: e-commerce platforms aggregate options for institutional and clinic buyers, while manufacturer websites provide product education, technical documentation, and direct ordering capabilities. These chained distribution structures influence pricing transparency, inventory visibility, and the speed at which new product iterations are adopted by clinical end users.

Based on end user, gastric band procedures are performed across ambulatory surgical centers, clinics, and hospitals, each with different procedural volumes, staffing models, and reimbursement interactions. Based on age group, the patient mix comprises adult and pediatric populations, with adult cohorts further segmented into 18-35, 36-50, and 51 plus age bands that reflect varied comorbidity profiles and lifestyle considerations. Based on gender, devices are used across female and male populations, and device design and counseling approaches must account for gender-specific outcomes, body composition differences, and patient preferences. Integrating these segmentation lenses enables targeted product messaging, tailored training programs, and optimized distribution strategies aligned with the realities of clinical practice.

Region-specific intelligence connecting procurement behavior, regulatory complexity, clinical training infrastructure, and patient expectations across the Americas, EMEA, and Asia-Pacific

Geographic context shapes clinical practice patterns, regulatory pathways, distribution logistics, and patient expectations in distinct ways across the world's principal regions. In the Americas, institutional purchasing tends to concentrate with large hospital systems and specialty networks that emphasize standardized procurement protocols, integrated care pathways, and consolidated vendor relationships. This environment favors devices supported by strong clinical training programs, efficient adjustment workflows, and clear service commitments to minimize variability in long-term follow-up.

In Europe, Middle East & Africa, the regulatory mosaic and reimbursement heterogeneity require flexible entry strategies that account for country-level reimbursement mechanisms and varied clinical infrastructure. Adoption in these territories is often influenced by national guideline endorsements, clinician networks that cross-border training programs, and distributor partnerships capable of navigating local logistics and regulatory requirements. Companies that invest in local evidence generation and clinician education generally find better uptake across diverse health systems.

In Asia-Pacific, rapid clinical capacity expansion and growing investment in minimally invasive surgical techniques create opportunities for devices that can be deployed with scalable training and support models. Distribution strategies in the region often combine direct sales in mature urban centers with distributor-led approaches in emerging markets. Moreover, patient preferences and demographic trends in Asia-Pacific emphasize early intervention and technology-enabled follow-up, which in turn influence product design priorities and aftercare service offerings. Across all regions, aligning regulatory, clinical, and commercial plans to regional characteristics is essential for sustainable adoption.

Competitive and partnership dynamics emphasizing product reliability, clinician education, aftermarket service excellence, and integrated care partnerships shaping sector leadership

Competitive dynamics among firms active in the gastric band space are shaped by capabilities in product engineering, clinical evidence generation, regulatory strategy, and postmarket support services. Leading companies combine iterative device improvements with robust clinician education programs and responsive aftermarket services, enabling surgical teams to adopt adjustable systems with confidence. The ability to demonstrate consistent device performance through registries and long-term follow-up contributes to clinician trust and institutional procurement favorability.

Strategically, some firms emphasize narrow product portfolios with depth in implant quality and procedural support, while others pursue broader portfolios that bundle related bariatric tools and consumables to capture more of the perioperative value chain. Distribution partnerships remain a core differentiator; companies that maintain both direct sales presence in key urban markets and agile distributor networks in more fragmented territories achieve greater coverage and responsiveness. In addition, investment in digital tools for patient engagement and remote follow-up enhances aftercare adherence and provides real-world data that can inform iterative product refinements.

From an M&A and partnership perspective, alliances between device innovators, surgical services providers, and digital health firms are increasingly common as companies seek to integrate device performance with care pathways and remote monitoring capabilities. Overall, firms that align product reliability, clinician training, evidence generation, and customer-centric service emerge as preferred partners for healthcare organizations implementing gastric band programs.

Practical and high-impact recommendations for aligning product innovation, clinician education, resilient distribution, and evidence generation to drive durable adoption

Industry leaders should prioritize a coordinated strategy that aligns product innovation, clinical engagement, and distribution resilience to secure sustainable clinical adoption. First, invest in device design enhancements that simplify perioperative handling and postoperative adjustment, while concurrently developing standardized clinician training curricula that reduce variability in outcomes and support rapid skill dissemination. Standardized protocols will facilitate smoother integration into hospital and ambulatory workflows and strengthen reimbursement discussions.

Second, build distribution strategies that balance direct sales presence in major markets with selective distributor partnerships in fragmented territories, complemented by regional warehousing to mitigate tariff and logistics disruptions. This hybrid approach enhances responsiveness while preserving cost efficiency. Third, accelerate evidence generation through registries and structured postmarket studies that capture patient-reported outcomes and long-term device performance, enabling sales and clinical affairs teams to address hesitations with empirical data.

Fourth, deploy digital patient engagement and remote monitoring solutions to enhance aftercare adherence and collect real-world insights that can inform iterative device improvements. Finally, pursue targeted collaborations-whether clinical, academic, or technological-to broaden the value proposition and demonstrate comprehensive care solutions. By operationalizing these priorities, leaders will enhance clinical trust, streamline procurement processes, and position their offerings for durable integration into multidisciplinary care pathways.

A rigorous mixed-methods research approach blending clinician interviews, regulatory and literature analysis, distributor intelligence, and expert review to ensure evidence-based conclusions

This research synthesized primary and secondary intelligence through a structured, multi-source approach designed to ensure rigor and transparency. Primary inputs included interviews with surgeons, ambulatory center directors, procurement professionals, distributor executives, and clinical affairs leaders to capture frontline perspectives on device handling, adjustment workflows, and purchasing considerations. These qualitative discussions were complemented by a systematic review of peer-reviewed clinical literature, regulatory filings, and device safety bulletins to validate technical claims and identify emerging safety signals.

Secondary inputs encompassed company product literature, procedural training materials, and publicly available guidelines that contextualize clinical practice patterns. Data validation comprised cross-referencing interview findings with published clinical outcomes and device performance reports, followed by triangulation across multiple stakeholders to reconcile divergent viewpoints. In addition, geographic analyses integrated inputs from regional distribution partners and health system procurement officers to map regulatory and logistical constraints.

Finally, methodological safeguards included independent expert review of clinical interpretations and a documented audit trail for source attribution. While proprietary commercial terms and contract-level pricing were not disclosed, the methodology prioritized transparency, reproducibility, and stakeholder balance to produce insights that are both robust and operationally relevant.

A strategic synthesis identifying core priorities-clinical value, distribution resilience, evidence generation, and postmarket support-that determine durable adoption of gastric band solutions

In conclusion, the contemporary gastric band landscape is characterized by refined device engineering, evolving clinical pathways, and an increasing emphasis on postmarket evidence and supply chain resilience. Adjustable, saline-filled systems remain central to discussions about titratable therapy and long-term patient management, but successful adoption depends as much on clinician training, accessible follow-up, and distribution agility as on device features alone. Regulatory expectations and payer scrutiny have elevated the importance of demonstrable safety and patient-centered outcomes in procurement deliberations.

Operational challenges-exemplified by tariff-induced logistics adjustments-have highlighted the need for diversified sourcing and transparent procurement practices. Regionally, differentiated strategies that respect local regulatory frameworks, reimbursement environments, and clinical infrastructure will be essential for sustained deployment. Finally, companies that integrate reliable products with comprehensive clinician education, digital aftercare tools, and robust real-world evidence programs will be best positioned to meet the needs of healthcare providers and patients alike.

Collectively, these conclusions point toward a pragmatic path forward: prioritize tangible clinical value, reinforce distribution and service capabilities, and invest in evidence generation that supports confident clinical and institutional adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastric Bands Market, by Product Type

  • 8.1. Adjustable
  • 8.2. Non Adjustable

9. Gastric Bands Market, by Age Group

  • 9.1. Adult
    • 9.1.1. 18-35
    • 9.1.2. 36-50
    • 9.1.3. 51 Plus
  • 9.2. Pediatric

10. Gastric Bands Market, by Gender

  • 10.1. Female
  • 10.2. Male

11. Gastric Bands Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
    • 11.2.1. Online Channels
      • 11.2.1.1. E Commerce Platforms
      • 11.2.1.2. Manufacturer Website
    • 11.2.2. Third Party Distributors

12. Gastric Bands Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Gastric Bands Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Gastric Bands Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Gastric Bands Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Gastric Bands Market

17. China Gastric Bands Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Allergan plc
  • 18.6. Apollo Endosurgery, Inc.
  • 18.7. Cousin Biotech SAS
  • 18.8. Endo Tools Therapeutics S.A.
  • 18.9. EndoGastric Solutions, Inc.
  • 18.10. Ethicon Endo-Surgery, LLC
  • 18.11. Hangzhou Kangning Medical Instruments Co., Ltd.
  • 18.12. Hologic, Inc.
  • 18.13. JOHNSON & JOHNSON SERVICES, INC.
  • 18.14. Karl Storz SE & Co. KG
  • 18.15. Mediflex Surgical Products
  • 18.16. Medline Industries, LP
  • 18.17. Medtronic Plc
  • 18.18. New York Bariatric Group's
  • 18.19. Obtech Medical AG
  • 18.20. ReShape Lifesciences Inc.
  • 18.21. SILIMED INDUSTRIA DE IMPANTES LTDA
  • 18.22. Spatz FGIA Inc.
  • 18.23. Surgical Tools, Inc.
  • 18.24. TedPella Inc.
  • 18.25. USGI Medical
  • 18.26. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTRIC BANDS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTRIC BANDS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTRIC BANDS MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTRIC BANDS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTRIC BANDS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTRIC BANDS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADJUSTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADJUSTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADJUSTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTRIC BANDS MARKET SIZE, BY NON ADJUSTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTRIC BANDS MARKET SIZE, BY NON ADJUSTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTRIC BANDS MARKET SIZE, BY NON ADJUSTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTRIC BANDS MARKET SIZE, BY 18-35, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTRIC BANDS MARKET SIZE, BY 18-35, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTRIC BANDS MARKET SIZE, BY 18-35, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTRIC BANDS MARKET SIZE, BY 36-50, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTRIC BANDS MARKET SIZE, BY 36-50, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTRIC BANDS MARKET SIZE, BY 36-50, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTRIC BANDS MARKET SIZE, BY 51 PLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTRIC BANDS MARKET SIZE, BY 51 PLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTRIC BANDS MARKET SIZE, BY 51 PLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTRIC BANDS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTRIC BANDS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTRIC BANDS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTRIC BANDS MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTRIC BANDS MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTRIC BANDS MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTRIC BANDS MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTRIC BANDS MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTRIC BANDS MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTRIC BANDS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTRIC BANDS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTRIC BANDS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTRIC BANDS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTRIC BANDS MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTRIC BANDS MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTRIC BANDS MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTRIC BANDS MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTRIC BANDS MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTRIC BANDS MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTRIC BANDS MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTRIC BANDS MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTRIC BANDS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTRIC BANDS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTRIC BANDS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTRIC BANDS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTRIC BANDS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTRIC BANDS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTRIC BANDS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTRIC BANDS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTRIC BANDS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTRIC BANDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS GASTRIC BANDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTRIC BANDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GCC GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 151. GCC GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GCC GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 154. GCC GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 155. GCC GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. G7 GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. G7 GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. G7 GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 178. G7 GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 179. G7 GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. G7 GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 181. G7 GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. NATO GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. NATO GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. NATO GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. NATO GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 187. NATO GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 188. NATO GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. NATO GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 190. NATO GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 191. NATO GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL GASTRIC BANDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA GASTRIC BANDS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA GASTRIC BANDS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA GASTRIC BANDS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA GASTRIC BANDS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA GASTRIC BANDS MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA GASTRIC BANDS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA GASTRIC BANDS MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA GASTRIC BANDS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)